Healthcare management platform Spreemo gains new investor

Pamplona Capital Management has announced that it made a “significant investment” in Spreemo, a healthcare management platform with an early focus on radiology-related services for the workers’ compensation market.

“We are excited to support Spreemo’s rapid growth both in its core market of diagnostic radiology for injured workers and its expansion ambitions,” Pamplona Capital partner Jeremy Gelber, MD, said in a statement. "We believe that Spreemo's transparent marketplace model can disrupt traditional healthcare in order to improve patient outcomes and lower employer’s costs.”

New York-based Spreemo was founded in 2010. The company’s platform is currently used to route injured employees to nearby, highly rated radiologists and imaging centers, but its long-term goal is to go beyond workers compensation and into mainstream insurance markets.

“Spreemo is thrilled to partner with Pamplona Capital to move to the next level of scalability and market penetration,” Ron Vianu, Spreemo CEO and co-founder, said in the statement. “Pamplona has a strong track record of healthcare investments, and their financial expertise and industry knowledge will be invaluable as we continue to grow.”

According to Pamplona’s statement, Spreemo is responsible for “tens of millions of workers and now include two of the three largest supermarket chains, two of the largest pharmacy chains and several of the top 20 largest insurance companies.” It has grown from being in five states last year to offering a network of providers across the United States in 2015.

Pamplona was founded in 2005 and has offices in London and New York, The exact figures of its investment have not been made public.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Trimed Popup
Trimed Popup